FDA Approves Tivicay (Dolutegravir) for Treatment of HIV-1

The FDA has approved Tivicay , a new drug to treat human immunodeficiency virus-1 infection.

http://www.pharmscope.com/news/DailyDetail.cfm?chosen=67678